AGP Picks
View all

Tonga Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tonga Healthcare Daily.

Press releases published on September 3, 2026

Fortrea übernimmt Einheit für klinische Pharmakologie und bioanalytische Laboraktivitäten von Worldwide Clinical Trials
Fortrea adquirirá de Worldwide Clinical Trials las operaciones de la Unidad de Farmacología Clínica y del Laboratorio de Bioanálisis
Fortrea acquiert l’unité de pharmacologie clinique et les activités de laboratoire bioanalytique de Worldwide Clinical Trials
Fortrea תרכוש את היחידה לפרמקולוגיה קלינית ואת פעילות המעבדה הביו-אנליטית של Worldwide Clinical Trials
フォートリア、ワールドワイド・クリニカル・トライアルズから臨床薬理部門およびバイオアナリシスラボ事業を買収
Fortrea Akan Mengakuisisi Unit Farmakologi Klinis dan Operasional Laboratorium Bionalitik dari Worldwide Clinical Trials
Fortrea, Worldwide Clinical Trials의 임상약리 유닛·생물분석 연구소 사업 인수
Fortrea Akan Mengambil Alih Unit Farmakologi Klinikal dan Operasi Makmal Bioanalisis daripada Worldwide Clinical Trials
Fortrea Adquire Unidade de Farmacologia Clínica e Operações de Laboratório Bioanalítico da Worldwide Clinical Trials
Fortrea 将收购 Worldwide Clinical Trials 的临床药理部门和生物分析实验室业务
Fortrea 將收購 Worldwide Clinical Trials 的臨床藥理學部門及生物分析實驗室業務
Fortrea เข้าซื้อกิจการหน่วยเภสัชวิทยาคลินิกและการปฏิบัติการห้องปฏิบัติการวิเคราะห์ทางชีวภาพจาก Worldwide Clinical Trial…
Fangzhou’s AI-Powered Chronic Care Model Named to Fortune China’s Best Designs 2026
Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress
Tensive to receive €20 million from EIB to commercialize bioresorbable breast implant
Egetis Therapeutics to Participate in Upcoming Investor Conferences in September
Commure Ambient AI Achieves Class I Certification and MHRA Registration
ONWARD Medical Announces First Implant in New Clinical Feasibility Study Evaluating ARC-IM System to Restore Mobility After Spinal Cord Injury
LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China
HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tonga Healthcare Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.